Anti-diabetic activities of fucosterol from Pelvetia siliquosa

Arch Pharm Res. 2004 Nov;27(11):1120-2. doi: 10.1007/BF02975115.

Abstract

Fucosterol isolated from Pelvetia siliquosa was tested for its anti-diabetic activity in vivo. Fucosterol, when administered orally at 30 mg/kg in streptozotocin-induced diabetic rats, was caused a significant decrease in serum glucose concentrations, and exhibited an inhibition of sorbitol accumulations in the lenses. Fucosterol, when administered orally at 300 mg/kg in epinephrine-induced diabetic rats, was also caused an inhibition of blood glucose level and glycogen degradation. These results demonstrated that fucosterol is a main anti-diabetic principle from the marine algae P. siliquosa.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blood Glucose / drug effects
  • Blood Glucose / metabolism
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / prevention & control*
  • Dose-Response Relationship, Drug
  • Liver / drug effects
  • Liver / metabolism
  • Liver Glycogen / metabolism
  • Male
  • Mice
  • Phaeophyceae / chemistry*
  • Rats
  • Rats, Sprague-Dawley
  • Rhodanine / analogs & derivatives*
  • Rhodanine / pharmacology
  • Stigmasterol / analogs & derivatives*
  • Stigmasterol / chemistry
  • Stigmasterol / isolation & purification
  • Stigmasterol / pharmacology*
  • Thiazolidines

Substances

  • Blood Glucose
  • Liver Glycogen
  • Thiazolidines
  • epalrestat
  • fucosterol
  • Rhodanine
  • Stigmasterol